Pacific Compounding Pharmacy & Consultations Inc

FDA Regulatory Profile

Pacific Compounding Pharmacy & Consultations Inc appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1076-2019, Class II) was initiated on August 23, 2018.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1076-2019Class IICefuroxime 10mg/mL INJ 0.5 mg, SDV, Rx only, Pacific Compounding, Stockton, CAAugust 23, 2018